We observed that in cervical cancer cells, this down-regulation was impaired by TG + GlcN, resulting in an increased IGF1R receptor activation (Fig. 3a) and signaling through the PI-3 kinase/Akt pathway (Fig. 4). The gene discussed is AKT1; the disease is cervical cancer.